2023-508030-33-00已完成4 期
A study in two groups of healthy male adult participants to assess how much test medicine (SAR441566) is taken up, degraded and removed by the body and to assess the extent to which SAR441566 becomes available to the body when given by mouth
Sanofi-Aventis Recherche & Developpement1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2024年2月27日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 13
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Sciences and Operations
Scientific
Sanofi-Aventis Recherche & Developpement
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study in healthy men to test how well different doses of BI 3776528 are tolerated2024-515222-92-00Boehringer Ingelheim International GmbH118
已完成
1 期
A study in healthy men to test how well different doses of BI 3731579 are tolerated2023-510318-25-00Boehringer Ingelheim International GmbH64
招募中
1 期
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood2025-521095-66-00Boehringer Ingelheim International GmbH68
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16
暂停
1 期
A study in healthy men to test how BI 1839100 is taken up and handled by the body2024-510870-26-00Boehringer Ingelheim International GmbH16